A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy

Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures

(2017) Graciana L. Galiana et al.   Drugs in research & development

Assessing long-term effects of eslicarbazepine acetate on lipid metabolism profile, sodium values and liver function tests

(2015) M. Ley et al.   EPILEPSY RESEARCH

The effect of topiramate and lamotrigine on rat bone mass, structure and metabolism

(2014) Julius Simko et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy

(2013) Dae Lim Koo et al.   EPILEPSY RESEARCH

May Long Term Oxcarbazepine Treatment Be Lead to Secondary Hyperparathyroidism?

(2012) O. Babacan et al.   Journal of Clinical Neurology

Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs

(2010) Matti J. Välimäki et al.   JOURNAL OF BONE AND MINERAL RESEARCH

The Effect of Oxcarbazepine on Bone Metabolism

(2009) Y. Çetinkaya et al.   ACTA NEUROLOGICA SCANDINAVICA

Predictors of bone density in ambulatory patients on antiepileptic drugs

(2008) Ghada El-Hajj Fuleihan et al.   BONE

Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy

(2008) A. M. Pack et al.   NEUROLOGY

Evaluation of Bone Turnover in Epileptic Children Using Oxcarbazepine

(2008) Ali Cansu et al.   PEDIATRIC NEUROLOGY